Home > Publications Database > η-Secretase processing of APP inhibits neuronal activity in the hippocampus. > print |
001 | 138158 | ||
005 | 20240321220401.0 | ||
024 | 7 | _ | |a 10.1038/nature14864 |2 doi |
024 | 7 | _ | |a pmid:26322584 |2 pmid |
024 | 7 | _ | |a pmc:PMC6570618 |2 pmc |
024 | 7 | _ | |a 0028-0836 |2 ISSN |
024 | 7 | _ | |a 1476-4687 |2 ISSN |
024 | 7 | _ | |a altmetric:4455229 |2 altmetric |
037 | _ | _ | |a DZNE-2020-04480 |
041 | _ | _ | |a English |
082 | _ | _ | |a 500 |
100 | 1 | _ | |a Willem, Michael |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
245 | _ | _ | |a η-Secretase processing of APP inhibits neuronal activity in the hippocampus. |
260 | _ | _ | |a London [u.a.] |c 2015 |b Nature Publ. Group65848 |
264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2015-08-31 |
264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2015-10-01 |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1591962874_16338 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a Alzheimer disease (AD) is characterized by the accumulation of amyloid plaques, which are predominantly composed of amyloid-β peptide. Two principal physiological pathways either prevent or promote amyloid-β generation from its precursor, β-amyloid precursor protein (APP), in a competitive manner. Although APP processing has been studied in great detail, unknown proteolytic events seem to hinder stoichiometric analyses of APP metabolism in vivo. Here we describe a new physiological APP processing pathway, which generates proteolytic fragments capable of inhibiting neuronal activity within the hippocampus. We identify higher molecular mass carboxy-terminal fragments (CTFs) of APP, termed CTF-η, in addition to the long-known CTF-α and CTF-β fragments generated by the α- and β-secretases ADAM10 (a disintegrin and metalloproteinase 10) and BACE1 (β-site APP cleaving enzyme 1), respectively. CTF-η generation is mediated in part by membrane-bound matrix metalloproteinases such as MT5-MMP, referred to as η-secretase activity. η-Secretase cleavage occurs primarily at amino acids 504-505 of APP695, releasing a truncated ectodomain. After shedding of this ectodomain, CTF-η is further processed by ADAM10 and BACE1 to release long and short Aη peptides (termed Aη-α and Aη-β). CTFs produced by η-secretase are enriched in dystrophic neurites in an AD mouse model and in human AD brains. Genetic and pharmacological inhibition of BACE1 activity results in robust accumulation of CTF-η and Aη-α. In mice treated with a potent BACE1 inhibitor, hippocampal long-term potentiation was reduced. Notably, when recombinant or synthetic Aη-α was applied on hippocampal slices ex vivo, long-term potentiation was lowered. Furthermore, in vivo single-cell two-photon calcium imaging showed that hippocampal neuronal activity was attenuated by Aη-α. These findings not only demonstrate a major functionally relevant APP processing pathway, but may also indicate potential translational relevance for therapeutic strategies targeting APP processing. |
536 | _ | _ | |a 342 - Disease Mechanisms and Model Systems (POF3-342) |0 G:(DE-HGF)POF3-342 |c POF3-342 |f POF III |x 0 |
536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 1 |
542 | _ | _ | |i 2015-08-31 |2 Crossref |u http://www.springer.com/tdm |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
650 | _ | 7 | |a APP protein, human |2 NLM Chemicals |
650 | _ | 7 | |a Amyloid beta-Protein Precursor |2 NLM Chemicals |
650 | _ | 7 | |a Membrane Proteins |2 NLM Chemicals |
650 | _ | 7 | |a Peptide Fragments |2 NLM Chemicals |
650 | _ | 7 | |a Amyloid Precursor Protein Secretases |0 EC 3.4.- |2 NLM Chemicals |
650 | _ | 7 | |a Aspartic Acid Endopeptidases |0 EC 3.4.23.- |2 NLM Chemicals |
650 | _ | 7 | |a BACE1 protein, human |0 EC 3.4.23.46 |2 NLM Chemicals |
650 | _ | 7 | |a Bace1 protein, mouse |0 EC 3.4.23.46 |2 NLM Chemicals |
650 | _ | 7 | |a ADAM Proteins |0 EC 3.4.24.- |2 NLM Chemicals |
650 | _ | 7 | |a Matrix Metalloproteinases, Membrane-Associated |0 EC 3.4.24.- |2 NLM Chemicals |
650 | _ | 7 | |a Mmp24 protein, mouse |0 EC 3.4.24.- |2 NLM Chemicals |
650 | _ | 7 | |a ADAM10 Protein |0 EC 3.4.24.81 |2 NLM Chemicals |
650 | _ | 7 | |a ADAM10 protein, human |0 EC 3.4.24.81 |2 NLM Chemicals |
650 | _ | 2 | |a ADAM Proteins: metabolism |2 MeSH |
650 | _ | 2 | |a ADAM10 Protein |2 MeSH |
650 | _ | 2 | |a Alzheimer Disease: enzymology |2 MeSH |
650 | _ | 2 | |a Alzheimer Disease: metabolism |2 MeSH |
650 | _ | 2 | |a Amyloid Precursor Protein Secretases: antagonists & inhibitors |2 MeSH |
650 | _ | 2 | |a Amyloid Precursor Protein Secretases: cerebrospinal fluid |2 MeSH |
650 | _ | 2 | |a Amyloid Precursor Protein Secretases: deficiency |2 MeSH |
650 | _ | 2 | |a Amyloid Precursor Protein Secretases: genetics |2 MeSH |
650 | _ | 2 | |a Amyloid Precursor Protein Secretases: metabolism |2 MeSH |
650 | _ | 2 | |a Amyloid beta-Protein Precursor: cerebrospinal fluid |2 MeSH |
650 | _ | 2 | |a Amyloid beta-Protein Precursor: chemistry |2 MeSH |
650 | _ | 2 | |a Amyloid beta-Protein Precursor: genetics |2 MeSH |
650 | _ | 2 | |a Amyloid beta-Protein Precursor: metabolism |2 MeSH |
650 | _ | 2 | |a Animals |2 MeSH |
650 | _ | 2 | |a Aspartic Acid Endopeptidases: antagonists & inhibitors |2 MeSH |
650 | _ | 2 | |a Aspartic Acid Endopeptidases: deficiency |2 MeSH |
650 | _ | 2 | |a Aspartic Acid Endopeptidases: genetics |2 MeSH |
650 | _ | 2 | |a Aspartic Acid Endopeptidases: metabolism |2 MeSH |
650 | _ | 2 | |a Calcium Signaling |2 MeSH |
650 | _ | 2 | |a Disease Models, Animal |2 MeSH |
650 | _ | 2 | |a Female |2 MeSH |
650 | _ | 2 | |a Hippocampus: cytology |2 MeSH |
650 | _ | 2 | |a Hippocampus: enzymology |2 MeSH |
650 | _ | 2 | |a Hippocampus: physiology |2 MeSH |
650 | _ | 2 | |a Humans |2 MeSH |
650 | _ | 2 | |a In Vitro Techniques |2 MeSH |
650 | _ | 2 | |a Long-Term Potentiation |2 MeSH |
650 | _ | 2 | |a Male |2 MeSH |
650 | _ | 2 | |a Matrix Metalloproteinases, Membrane-Associated: deficiency |2 MeSH |
650 | _ | 2 | |a Matrix Metalloproteinases, Membrane-Associated: metabolism |2 MeSH |
650 | _ | 2 | |a Membrane Proteins: metabolism |2 MeSH |
650 | _ | 2 | |a Mice |2 MeSH |
650 | _ | 2 | |a Molecular Weight |2 MeSH |
650 | _ | 2 | |a Neurites: enzymology |2 MeSH |
650 | _ | 2 | |a Neurites: metabolism |2 MeSH |
650 | _ | 2 | |a Neurons: enzymology |2 MeSH |
650 | _ | 2 | |a Neurons: physiology |2 MeSH |
650 | _ | 2 | |a Peptide Fragments: chemistry |2 MeSH |
650 | _ | 2 | |a Peptide Fragments: metabolism |2 MeSH |
650 | _ | 2 | |a Plaque, Amyloid |2 MeSH |
650 | _ | 2 | |a Protein Processing, Post-Translational |2 MeSH |
650 | _ | 2 | |a Proteolysis |2 MeSH |
650 | _ | 2 | |a Single-Cell Analysis |2 MeSH |
700 | 1 | _ | |a Tahirovic, Sabina |0 P:(DE-2719)2442036 |b 1 |u dzne |
700 | 1 | _ | |a Busche, Marc Aurel |b 2 |
700 | 1 | _ | |a Ovsepian, Saak V |0 P:(DE-2719)9000407 |b 3 |u dzne |
700 | 1 | _ | |a Chafai, Magda |b 4 |
700 | 1 | _ | |a Kootar, Scherazad |b 5 |
700 | 1 | _ | |a Hornburg, Daniel |b 6 |
700 | 1 | _ | |a Evans, Lewis D B |b 7 |
700 | 1 | _ | |a Moore, Steven |b 8 |
700 | 1 | _ | |a Daria, Anna |b 9 |
700 | 1 | _ | |a Hampel, Heike |b 10 |
700 | 1 | _ | |a Müller, Veronika |b 11 |
700 | 1 | _ | |a Giudici, Camilla |0 P:(DE-HGF)0 |b 12 |
700 | 1 | _ | |a Nuscher, Brigitte |0 P:(DE-HGF)0 |b 13 |
700 | 1 | _ | |a Wenninger-Weinzierl, Andrea |0 P:(DE-2719)2810261 |b 14 |u dzne |
700 | 1 | _ | |a Kremmer, Elisabeth |0 P:(DE-2719)9000167 |b 15 |u dzne |
700 | 1 | _ | |a Heneka, Michael T |0 P:(DE-2719)2000008 |b 16 |u dzne |
700 | 1 | _ | |a Thal, Dietmar R |b 17 |
700 | 1 | _ | |a Giedraitis, Vilmantas |b 18 |
700 | 1 | _ | |a Lannfelt, Lars |b 19 |
700 | 1 | _ | |a Müller, Ulrike |b 20 |
700 | 1 | _ | |a Livesey, Frederick J |b 21 |
700 | 1 | _ | |a Meissner, Felix |b 22 |
700 | 1 | _ | |a Herms, Jochen |0 P:(DE-2719)2810441 |b 23 |u dzne |
700 | 1 | _ | |a Konnerth, Arthur |b 24 |
700 | 1 | _ | |a Marie, Hélène |b 25 |
700 | 1 | _ | |a Haass, Christian |0 P:(DE-2719)2202037 |b 26 |e Last author |u dzne |
773 | 1 | 8 | |a 10.1038/nature14864 |b : Springer Science and Business Media LLC, 2015-08-31 |n 7573 |p 443-447 |3 journal-article |2 Crossref |t Nature |v 526 |y 2015 |x 0028-0836 |
773 | _ | _ | |a 10.1038/nature14864 |g Vol. 526, no. 7573, p. 443 - 447 |0 PERI:(DE-600)1413423-8 |n 7573 |q 526:7573<443 - 447 |p 443-447 |t Nature |v 526 |y 2015 |x 0028-0836 |
856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570618 |
909 | C | O | |o oai:pub.dzne.de:138158 |p VDB |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2442036 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)9000407 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 14 |6 P:(DE-2719)2810261 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 15 |6 P:(DE-2719)9000167 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 16 |6 P:(DE-2719)2000008 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 23 |6 P:(DE-2719)2810441 |
910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 26 |6 P:(DE-2719)2202037 |
913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-342 |2 G:(DE-HGF)POF3-300 |v Disease Mechanisms and Model Systems |x 0 |
913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |2 G:(DE-HGF)POF3-300 |v Clinical and Health Care Research |x 1 |
914 | 1 | _ | |y 2015 |
915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b NATURE : 2017 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1060 |2 StatID |b Current Contents - Agriculture, Biology and Environmental Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1150 |2 StatID |b Current Contents - Physical, Chemical and Earth Sciences |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
915 | _ | _ | |a IF >= 40 |0 StatID:(DE-HGF)9940 |2 StatID |b NATURE : 2017 |
920 | 1 | _ | |0 I:(DE-2719)1140003 |k AG Tahirovic |l Ex vivo models |x 0 |
920 | 1 | _ | |0 I:(DE-2719)1110001 |k AG Herms |l Translational Brain Research |x 1 |
920 | 1 | _ | |0 I:(DE-2719)1110007 |k AG Haass old |l ALS, FTLD and Zebrafish models |x 2 |
920 | 1 | _ | |0 I:(DE-2719)5000050 |k Ext HZM |l Ext HZM |x 3 |
920 | 1 | _ | |0 I:(DE-2719)1011303 |k AG Heneka2 |l Neuroinflammation, Biomarker |x 4 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-2719)1140003 |
980 | _ | _ | |a I:(DE-2719)1110001 |
980 | _ | _ | |a I:(DE-2719)5000015 |
980 | _ | _ | |a I:(DE-2719)5000050 |
980 | _ | _ | |a I:(DE-2719)1011303 |
980 | _ | _ | |a UNRESTRICTED |
999 | C | 5 | |a 10.1038/nrm2101 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nrm2101 |
999 | C | 5 | |a 10.1523/JNEUROSCI.0540-14.2014 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.0540-14.2014 |
999 | C | 5 | |a 10.1038/357500a0 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/357500a0 |
999 | C | 5 | |a 10.1126/science.1738846 |9 -- missing cx lookup -- |2 Crossref |o 10.1126/science.1738846 |
999 | C | 5 | |y 1993 |2 Crossref |o C Haass 1993 |
999 | C | 5 | |a 10.1016/0092-8674(94)90066-3 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0092-8674(94)90066-3 |
999 | C | 5 | |a 10.1038/nature07767 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nature07767 |
999 | C | 5 | |a 10.1074/jbc.M111.252718 |9 -- missing cx lookup -- |2 Crossref |o 10.1074/jbc.M111.252718 |
999 | C | 5 | |a 10.1096/fj.11-200295 |9 -- missing cx lookup -- |2 Crossref |o 10.1096/fj.11-200295 |
999 | C | 5 | |a 10.1038/sj.embor.7400784 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/sj.embor.7400784 |
999 | C | 5 | |a 10.3233/JAD-2012-120994 |9 -- missing cx lookup -- |2 Crossref |o 10.3233/JAD-2012-120994 |
999 | C | 5 | |a 10.1021/bi5003053 |9 -- missing cx lookup -- |2 Crossref |o 10.1021/bi5003053 |
999 | C | 5 | |a 10.1021/bi020643m |9 -- missing cx lookup -- |2 Crossref |o 10.1021/bi020643m |
999 | C | 5 | |a 10.1093/jb/mvj054 |9 -- missing cx lookup -- |2 Crossref |o 10.1093/jb/mvj054 |
999 | C | 5 | |a 10.1073/pnas.0908507106 |9 -- missing cx lookup -- |2 Crossref |o 10.1073/pnas.0908507106 |
999 | C | 5 | |a 10.1073/pnas.060037197 |9 -- missing cx lookup -- |2 Crossref |o 10.1073/pnas.060037197 |
999 | C | 5 | |a 10.1038/nprot.2012.116 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nprot.2012.116 |
999 | C | 5 | |a 10.1074/jbc.274.10.6483 |9 -- missing cx lookup -- |2 Crossref |o 10.1074/jbc.274.10.6483 |
999 | C | 5 | |a 10.1038/85064 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/85064 |
999 | C | 5 | |a 10.1038/416535a |9 -- missing cx lookup -- |2 Crossref |o 10.1038/416535a |
999 | C | 5 | |a 10.1523/JNEUROSCI.4970-06.2007 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.4970-06.2007 |
999 | C | 5 | |a 10.1038/nm1782 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nm1782 |
999 | C | 5 | |a 10.1126/science.1162844 |9 -- missing cx lookup -- |2 Crossref |o 10.1126/science.1162844 |
999 | C | 5 | |a 10.1073/pnas.1206171109 |9 -- missing cx lookup -- |2 Crossref |o 10.1073/pnas.1206171109 |
999 | C | 5 | |a 10.1038/sj.emboj.7600061 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/sj.emboj.7600061 |
999 | C | 5 | |a 10.1046/j.0953-816x.2001.01462.x |9 -- missing cx lookup -- |2 Crossref |o 10.1046/j.0953-816x.2001.01462.x |
999 | C | 5 | |a 10.1038/nature11283 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nature11283 |
999 | C | 5 | |a 10.1038/emboj.2012.173 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/emboj.2012.173 |
999 | C | 5 | |a 10.1074/jbc.M112.377465 |9 -- missing cx lookup -- |2 Crossref |o 10.1074/jbc.M112.377465 |
999 | C | 5 | |a 10.1074/jbc.270.16.9564 |9 -- missing cx lookup -- |2 Crossref |o 10.1074/jbc.270.16.9564 |
999 | C | 5 | |a 10.1038/nprot.2006.356 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nprot.2006.356 |
999 | C | 5 | |a 10.1038/nature10821 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nature10821 |
999 | C | 5 | |a 10.1038/nn.3041 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nn.3041 |
999 | C | 5 | |a 10.1523/JNEUROSCI.1405-14.2014 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.1405-14.2014 |
999 | C | 5 | |a 10.1016/j.jbbm.2006.04.002 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.jbbm.2006.04.002 |
999 | C | 5 | |a 10.1074/jbc.M410378200 |9 -- missing cx lookup -- |2 Crossref |o 10.1074/jbc.M410378200 |
999 | C | 5 | |a 10.1038/nprot.2007.261 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nprot.2007.261 |
999 | C | 5 | |a 10.1074/mcp.M114.043489 |9 -- missing cx lookup -- |2 Crossref |o 10.1074/mcp.M114.043489 |
999 | C | 5 | |a 10.1038/nmeth1060 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nmeth1060 |
999 | C | 5 | |a 10.1038/nbt.1511 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nbt.1511 |
999 | C | 5 | |a 10.1021/pr101065j |9 -- missing cx lookup -- |2 Crossref |o 10.1021/pr101065j |
999 | C | 5 | |y 2014 |2 Crossref |t R: A Language and Environment for Statistical Computing |o R Development Core Team R: A Language and Environment for Statistical Computing 2014 |
999 | C | 5 | |a 10.1038/nm1295-1291 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nm1295-1291 |
999 | C | 5 | |a 10.1212/WNL.34.7.939 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.34.7.939 |
999 | C | 5 | |a 10.1016/0304-3940(94)90463-4 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0304-3940(94)90463-4 |
999 | C | 5 | |a 10.1016/0304-3940(95)12059-D |9 -- missing cx lookup -- |2 Crossref |o 10.1016/0304-3940(95)12059-D |
999 | C | 5 | |a 10.1007/BF00308809 |9 -- missing cx lookup -- |2 Crossref |o 10.1007/BF00308809 |
999 | C | 5 | |a 10.1212/WNL.41.4.479 |9 -- missing cx lookup -- |2 Crossref |o 10.1212/WNL.41.4.479 |
999 | C | 5 | |a 10.1016/j.jalz.2011.10.007 |9 -- missing cx lookup -- |2 Crossref |o 10.1016/j.jalz.2011.10.007 |
999 | C | 5 | |a 10.1074/jbc.M403672200 |9 -- missing cx lookup -- |2 Crossref |o 10.1074/jbc.M403672200 |
999 | C | 5 | |a 10.1523/JNEUROSCI.0457-10.2010 |9 -- missing cx lookup -- |2 Crossref |o 10.1523/JNEUROSCI.0457-10.2010 |
999 | C | 5 | |a 10.1113/jphysiol.2005.103754 |9 -- missing cx lookup -- |2 Crossref |o 10.1113/jphysiol.2005.103754 |
999 | C | 5 | |a 10.1073/pnas.1232232100 |9 -- missing cx lookup -- |2 Crossref |o 10.1073/pnas.1232232100 |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|